Ipamorelin was identified as a synthetic pentapeptide that interacts with the ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R1a)
Its possible to (minimally) increase endogenous GLP-1 production from dietary shiftsbut that only very slightly increases the quantity of GLP-1 temporarily, and more importantly, it doesnt change the two-minute half-life
However, the Centers for Medicare & Medicaid Services (CMS) is considering expanding coverage of weight loss medications starting in 2026
Patients comfortable with compounded semaglutide can start for as low as $199/month, while those who want Wegovy, Ozempic, or tirzepatide can upgrade (though at higher cost)
Understanding what the research actually shows versus marketing claims is essential before considering this intervention
It is not conservative either